| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |